Abstract
Objective
Oral lichen planus (OLP) is one of the most common oral mucosa diseases, and is mainly mediated by T lymphocytes. The metabolic reprogramming of activated T cells has been shown to transform from oxidative phosphorylation to aerobic glycolysis. The present study investigated the serum levels of glycolysis-related molecules (lactate dehydrogenase, LDH; pyruvic acid, PA; lactic acid, LAC) in OLP, and the correlation with OLP activity was assessed using the reticular, atrophic and erosive lesion (RAE) scoring system.
Methods
Univariate and multivariate linear regression functions based on scikit-learn were designed to predict the RAE scores in OLP patients, and the performance of these two machine learning functions was compared.
Results
The results revealed that the serum levels of PA and LAC were upregulated in erosive OLP (EOLP) patients, when compared to healthy volunteers. Furthermore, the LDH and LAC levels were significantly higher in the EOLP group than in the nonerosive OLP (NEOLP) group. All glycolysis-related molecules were positively correlated to the RAE scores. Among these, LAC had a strong correlation. The univariate function that involved the LAC level and the multivariate function that involved all glycolysis-related molecules presented comparable prediction accuracy and stability, but the latter was more time-consuming.
Conclusion
It can be concluded that the serum LAC level can be a user-friendly biomarker to monitor the OLP activity, based on the univariate function developed in the present study. The intervention of the glycolytic pathway may provide a potential therapeutic strategy.
Electronic supplementary material
The online version of this article (10.1007/s11596-023-2716-7) contains supplementary material, which is available to authorized users.
Key words: oral lichen planus, glycolysis, lactic acid, linear regression, machine learning
Electronic Supplementary Material
Predicting the Activity of Oral Lichen Planus with Glycolysis-related Molecules: A Scikit-learn-based Function
Footnotes
This work was supported by grants from the National Natural Science Foundation of China (No. 62171193), the Natural Science Foundation of Hubei Province (No. 2021CFB399), the Foundation of Health Commission of Hubei Province (No. WJ2021M125), and the Key Research and Development Project of Hubei Province of China (No. 2022BCA033).
Conflict of Interest Statement
None of the authors have any potential financial conflicts of interest related to the study.
Contributor Information
Yan Yang, Email: yangyantj@hust.edu.cn.
Jing-yu Hu, Email: 2014tj0116@hust.edu.cn.
References
- 1.Society of Oral Medicine. Chinese Stomatological Association Guideline for the diagnosis and treatment of oral lichen planus (revision) Zhonghua Kou Qiang Yi Xue Za Zhi (Chinese) 2022;57(2):115–121. doi: 10.3760/cma.j.cn112144-20211115-00505. [DOI] [PubMed] [Google Scholar]
- 2.van der Meij EH, Mast H, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol. 2007;43(8):742–748. doi: 10.1016/j.oraloncology.2006.09.006. [DOI] [PubMed] [Google Scholar]
- 3.Zhou G, Zhang J, Ren XW, et al. Increased B7-H1 expression on peripheral blood T cells in oral lichen planus correlated with disease severity. J Clin Immunol. 2012;32(4):794–801. doi: 10.1007/s10875-012-9683-2. [DOI] [PubMed] [Google Scholar]
- 4.Hu JY, Zhang J, Cui JL, et al. Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus. Cytokine. 2013;62(1):141–145. doi: 10.1016/j.cyto.2013.01.020. [DOI] [PubMed] [Google Scholar]
- 5.Hu JY, Zhang J, Ma JZ, et al. MicroRNA-155-IFN-gamma Feedback Loop in CD4(+)T Cells of Erosive type Oral Lichen Planus. Sci Rep. 2015;5:16935. doi: 10.1038/srep16935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lu R, Zhou G, Du G, et al. Expression of T-bet and GATA-3 in peripheral blood mononuclear cells of patients with oral lichen planus. Arch Oral Biol. 2011;56(5):499–505. doi: 10.1016/j.archoralbio.2010.11.006. [DOI] [PubMed] [Google Scholar]
- 7.Xie S, Ding L, Xiong Z, et al. Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus. J Huazhong Univ Sci Tech Med Sci. 2012;32(3):451–457. doi: 10.1007/s11596-012-0078-7. [DOI] [PubMed] [Google Scholar]
- 8.Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8(7):523–532. doi: 10.1038/nri2343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Zhou L, Cao T, Wang Y, et al. Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus. Inflammation. 2016;39(3):1205–1215. doi: 10.1007/s10753-016-0356-9. [DOI] [PubMed] [Google Scholar]
- 10.Dumitru C, Kabat AM, Maloy KJ. Metabolic Adaptations of CD4(+) T Cells in Inflammatory Disease. Front Immunol. 2018;9:540. doi: 10.3389/fimmu.2018.00540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bantug GR, Galluzzi L, Kroemer G, et al. The spectrum of T cell metabolism in health and disease. Nat Rev Immunol. 2018;18(1):19–34. doi: 10.1038/nri.2017.99. [DOI] [PubMed] [Google Scholar]
- 12.Gerriets VA, Kishton RJ, Johnson MO, et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat Immunol. 2016;17(12):1459–1466. doi: 10.1038/ni.3577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Chen X, Lin H, Yang D, et al. Early-life undernutrition reprograms CD4(+) T-cell glycolysis and epigenetics to facilitate asthma. J Allergy Clin Immunol. 2019;143(6):2038–2051.e12. doi: 10.1016/j.jaci.2018.12.999. [DOI] [PubMed] [Google Scholar]
- 14.Michalek RD, Gerriets VA, Jacobs SR, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol. 2011;186(6):3299–3303. doi: 10.4049/jimmunol.1003613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Palsson-McDermott EM, O’Neill LA. The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays. 2013;35(11):965–973. doi: 10.1002/bies.201300084. [DOI] [PubMed] [Google Scholar]
- 16.Warburg O, Wind F, Negelein E. The Metabolism of Tumors in the Body. J Gen Physiol. 1927;8(6):519–530. doi: 10.1085/jgp.8.6.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Grist JT, Jarvis LB, Georgieva Z, et al. Extracellular Lactate: A Novel Measure of T Cell Proliferation. J Immunol. 2018;200(3):1220–1226. doi: 10.4049/jimmunol.1700886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Shanbehzadeh M, Afrash MR, Mirani N, et al. Comparing machine learning algorithms to predict 5-year survival in patients with chronic myeloid leukemia. BMC Med Inform Decis Mak. 2022;22(1):236. doi: 10.1186/s12911-022-01980-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Zhang G, Shi Y, Yin P, et al. A machine learning model based on ultrasound image features to assess the risk of sentinel lymph node metastasis in breast cancer patients: Applications of scikit-learn and SHAP. Front Oncol. 2022;12:944569. doi: 10.3389/fonc.2022.944569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Canto AM, Muller H, Freitas RR, et al. Oral lichen planus (OLP): clinical and complementary diagnosis. An Bras Dermatol. 2010;85(5):669–675. doi: 10.1590/S0365-05962010000500010. [DOI] [PubMed] [Google Scholar]
- 21.González-Moles M, Ruiz-Ávila I, González-Ruiz L, et al. Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis. Oral Oncol. 2019;96:121–130. doi: 10.1016/j.oraloncology.2019.07.012. [DOI] [PubMed] [Google Scholar]
- 22.Jäwert F, Nyman J, Olsson E, et al. Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer. Oral Oncol. 2021;121:105469. doi: 10.1016/j.oraloncology.2021.105469. [DOI] [PubMed] [Google Scholar]
- 23.Yin J, Yang X, Zeng Q, et al. The positive correlation of the CCL2-CCR2 axis with the disease activity may indicate the fundamental role in the pathogenesis of oral lichen planus. J Oral Pathol Med. 2016;45(1):41–47. doi: 10.1111/jop.12325. [DOI] [PubMed] [Google Scholar]
- 24.Zhu ZD, Ren XM, Zhou MM, et al. Salivary cytokine profile in patients with oral lichen planus. J Dent Sci. 2022;17(1):100–105. doi: 10.1016/j.jds.2021.06.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Aghbari SMH, Gaafar SM, Shaker OG, et al. Evaluating the accuracy of microRNA27b and microRNA137 as biomarkers of activity and potential malignant transformation in oral lichen planus patients. Arch Dermatol Res. 2018;310(3):209–220. doi: 10.1007/s00403-018-1805-0. [DOI] [PubMed] [Google Scholar]
- 26.Certo M, Tsai CH, Pucino V, et al. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol. 2021;21(3):151–161. doi: 10.1038/s41577-020-0406-2. [DOI] [PubMed] [Google Scholar]
- 27.Gupta GS. The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients. Inflammation. 2022;45(6):2091–2123. doi: 10.1007/s10753-022-01680-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wang F, Zhang J, Zhou G. The mTOR-glycolytic pathway promotes T-cell immunobiology in oral lichen planus. Immunobiology. 2020;225(3):151933. doi: 10.1016/j.imbio.2020.151933. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Predicting the Activity of Oral Lichen Planus with Glycolysis-related Molecules: A Scikit-learn-based Function
